| Field | Row 1 |
|---|---|
| adsh | 0001213900-25-042751 |
| cik | 1784058 |
| name | PONY GROUP INC. |
| sic | 7500 |
| countryba | CN |
| stprba | |
| cityba | SHENZHEN, GUANGDONG PROVINCE |
| zipba | 518000 |
| bas1 | ENGINEER EXPERIMENT BUILDING, A202 |
| bas2 | 7 GAOXIN SOUTH AVENUE, NANSHAN DISTRICT |
| baph | 86-0755-86665622 |
| countryma | CN |
| stprma | |
| cityma | SHENZHEN, GUANGDONG PROVINCE |
| zipma | 518000 |
| mas1 | ENGINEER EXPERIMENT BUILDING, A202 |
| mas2 | 7 GAOXIN SOUTH AVENUE, NANSHAN DISTRICT |
| countryinc | US |
| stprinc | DE |
| ein | 833532241 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250513 |
| accepted | 2025-05-13 17:09:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ea0239897-10q_pony_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-042751 | 20250331 | Accounts Payable Current | 6941.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 25618.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Additional Paid In Capital Common Stock | 176000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Assets | 17129.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 7640.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -3312.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Common Stock Shares Outstanding | 11500000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042751 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 6164.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | General And Administrative Expense | 60728.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -49452.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042751 | 20250331 | Increase Decrease In Accounts Receivable | -1.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Liabilities And Stockholders Equity | 13808.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20231231 | Stockholders Equity | -518130.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Stockholders Equity | 11500.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042751 | 20241231 | Stockholders Equity | 11500.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042751 | 20250331 | Stockholders Equity | -937946.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042751 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 15413.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Common Stock Shares Authorized | 70000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042751 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 6164.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042751 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-042751 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042751 | 20241231 | Other Liabilities Current | 52439.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Other Liabilities Current | 71413.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Other Notes Payable Current | 687618.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Wenxian Fan; | ||
| 0001213900-25-042751 | 20240331 | Stockholders Equity | -781021.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042751 | 20241231 | Stockholders Equity | 176000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042751 | 20240331 | Accounts Receivable Net Current | 5880.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Accounts Payable Current | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-042751 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Common Stock Shares Issued | 11500000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Cost Of Revenue | 7768.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Earnings Per Share Diluted | -0.0040 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -27336.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Increase Decrease In Other Operating Liabilities | -4959.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Liabilities | 692505.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Net Cash Provided By Used In Financing Activities | 50417.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Net Cash Provided By Used In Operating Activities | -23528.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042751 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -27336.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001213900-25-042751 | 20240331 | Other Nonoperating Income Expense | 10.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Proceeds From Related Party Debt | 50417.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20231231 | Stockholders Equity | 18790.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001213900-25-042751 | 20240331 | Stockholders Equity | 176000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042751 | 20241231 | Stockholders Equity | -888494.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042751 | 20241231 | Accounts Receivable Net Current | 5880.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Assets Current | 17129.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 10952.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Comprehensive Income Net Of Tax | -76788.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Earnings Per Share Basic | -0.0050 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Earnings Per Share Basic | -0.0040 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Increase Decrease In Accounts Payable | 6941.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Net Cash Provided By Used In Operating Activities | -57746.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042751 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-042751 | 20250331 | Net Income Loss | -49452.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042751 | 20240331 | Operating Income Loss | -56611.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Other Receivables Net Current | 289.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Revenues | 11885.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20231231 | Stockholders Equity | 11500.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042751 | 20231231 | Stockholders Equity | -724420.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042751 | 20250331 | Stockholders Equity | -752164.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 11500000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Cash And Cash Equivalents At Carrying Value | 7640.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Common Stock Shares Issued | 11500000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Common Stock Shares Outstanding | 11500000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Common Stock Value | 11500.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Comprehensive Income Net Of Tax | -50437.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Cost Of Revenue | 18644.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Earnings Per Share Diluted | -0.0050 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Increase Decrease In Other Receivables | -8.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Liabilities Current | 692505.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Net Income Loss | -56601.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042751 | 20250331 | Net Income Loss | -49452.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Operating Expenses | 60987.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Operating Income Loss | -49366.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-042751 | 20250331 | Stockholders Equity | -1718.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001213900-25-042751 | 20240331 | Net Income Loss | -56601.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042751 | 20250331 | Accounts Receivable Net Current | 5879.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Common Stock Shares Authorized | 70000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Common Stock Shares Outstanding | 11500000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Common Stock Value | 11500.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Gross Profit | 4117.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Increase Decrease In Accounts Receivable | -3837.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Increase Decrease In Other Operating Liabilities | 18974.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042751 | 20241231 | Other Notes Payable Current | 640066.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Wenxian Fan; | ||
| 0001213900-25-042751 | 20241231 | Other Receivables Net Current | 297.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Retained Earnings Accumulated Deficit | -888494.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20231231 | Stockholders Equity | 176000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042751 | 20240331 | Stockholders Equity | -568567.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Stockholders Equity | 24954.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001213900-25-042751 | 20250331 | Stockholders Equity | 176000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042751 | 20250331 | Additional Paid In Capital Common Stock | 176000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Assets Current | 13808.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Cash And Cash Equivalents At Carrying Value | 10952.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 16578.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1165.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | General And Administrative Expense | 60987.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Gross Profit | 11621.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -56601.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Increase Decrease In Accounts Payable | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042751 | 20240331 | Increase Decrease In Other Receivables | 23.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Liabilities And Stockholders Equity | 17129.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001213900-25-042751 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-042751 | 20240331 | Nonoperating Income Expense | 10.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Nonoperating Income Expense | -86.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Operating Expenses | 60728.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 6164.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001213900-25-042751 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -27336.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20240331 | Other Comprehensive Income Loss Net Of Tax | 6164.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Other Nonoperating Income Expense | -86.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Other Notes Payable Current | 687618.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-042751 | 20250331 | Retained Earnings Accumulated Deficit | -937946.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -1718.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Assets | 13808.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20231231 | Common Stock Shares Outstanding | 11500000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042751 | 20240331 | Common Stock Shares Outstanding | 11500000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042751 | 20241231 | Common Stock Shares Outstanding | 11500000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042751 | 20240331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042751 | 20250331 | Liabilities | 765972.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Liabilities Current | 765972.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Net Cash Provided By Used In Financing Activities | 47552.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Other Comprehensive Income Loss Net Of Tax | -27336.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Other Notes Payable Current | 640066.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-042751 | 20250331 | Proceeds From Related Party Debt | 47552.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20250331 | Revenues | 30265.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Stockholders Equity | -675376.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042751 | 20241231 | Stockholders Equity | 25618.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001213900-25-042751 | 20250331 | Stockholders Equity | 11500.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042751 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 11500000.0000 | shares | 1 | us-gaap/2025 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Other Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Comprehensive Income Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Other Notes Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Notes Payable, Current | Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer. |
| Proceeds From Related Party Debt | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Accounts Receivable Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Cost Of Revenue | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Other Receivables Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Receivables, Net, Current | Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer. |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Other Operating Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Operating Liabilities | Amount of increase (decrease) in operating liabilities classified as other. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Increase Decrease In Accounts Receivable | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Other Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Increase Decrease In Other Receivables | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Receivables | Amount of increase (decrease) in receivables classified as other. |
| Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax | Amount after tax and reclassification adjustments of other comprehensive income (loss). |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Gross Profit | us-gaap/2025 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Revenues | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Additional Paid In Capital Common Stock | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-042751 | 2 | 7 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001213900-25-042751 | 2 | 8 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2025 | Accounts receivable | 0 |
| 0001213900-25-042751 | 2 | 9 | BS | 0 | H | Other Receivables Net Current | us-gaap/2025 | Other receivables | 0 |
| 0001213900-25-042751 | 2 | 10 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001213900-25-042751 | 2 | 11 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001213900-25-042751 | 2 | 13 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001213900-25-042751 | 2 | 14 | BS | 0 | H | Other Notes Payable Current | us-gaap/2025 | Other payable-related parties | 0 |
| 0001213900-25-042751 | 2 | 15 | BS | 0 | H | Other Liabilities Current | us-gaap/2025 | Other liabilities | 0 |
| 0001213900-25-042751 | 2 | 16 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001213900-25-042751 | 2 | 17 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
| 0001213900-25-042751 | 2 | 19 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, $0.001 par value, 70,000,000 shares authorized, 11,500,000 shares issued and outstanding as of March 31, 2025 and December 31, 2024 | 0 |
| 0001213900-25-042751 | 2 | 20 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001213900-25-042751 | 2 | 21 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | Accumulated other comprehensive income | 0 |
| 0001213900-25-042751 | 2 | 22 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001213900-25-042751 | 2 | 23 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total stockholders equity | 0 |
| 0001213900-25-042751 | 2 | 24 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and stockholders equity | 0 |
| 0001213900-25-042751 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in Dollars per share) | 0 |
| 0001213900-25-042751 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized | 0 |
| 0001213900-25-042751 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued | 0 |
| 0001213900-25-042751 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding | 0 |
| 0001213900-25-042751 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2025 | Revenue | 0 |
| 0001213900-25-042751 | 4 | 2 | IS | 0 | H | Cost Of Revenue | us-gaap/2025 | Cost of revenue | 0 |
| 0001213900-25-042751 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2025 | Gross profit | 0 |
| 0001213900-25-042751 | 4 | 5 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General & administrative expenses | 0 |
| 0001213900-25-042751 | 4 | 6 | IS | 0 | H | Operating Expenses | us-gaap/2025 | Total operating expenses | 0 |
| 0001213900-25-042751 | 4 | 7 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Loss from operation | 0 |
| 0001213900-25-042751 | 4 | 9 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2025 | Other (expense) income | 0 |
| 0001213900-25-042751 | 4 | 10 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2025 | Total other (expense) income | 0 |
| 0001213900-25-042751 | 4 | 11 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | Loss before income taxes | 0 |
| 0001213900-25-042751 | 4 | 12 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Provision for income tax | 1 |
| 0001213900-25-042751 | 4 | 13 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net Loss | 0 |
| 0001213900-25-042751 | 4 | 14 | IS | 0 | H | Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | Other Comprehensive Income (Loss) | 0 |
| 0001213900-25-042751 | 4 | 15 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2025 | Comprehensive loss | 0 |
| 0001213900-25-042751 | 4 | 16 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Basic loss per share of common stock (in Dollars per share) | 0 |
| 0001213900-25-042751 | 4 | 17 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Diluted loss per share of common stock (in Dollars per share) | 0 |
| 0001213900-25-042751 | 4 | 18 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted average number of shares outstanding (in Shares) | 0 |
| 0001213900-25-042751 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-042751 | 5 | 10 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-042751 | 5 | 11 | EQ | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2025 | Cumulative Foreign currency translation adjustment | 0 |
| 0001213900-25-042751 | 5 | 12 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net Loss | 0 |
| 0001213900-25-042751 | 5 | 13 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-042751 | 5 | 14 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-042751 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net Loss | 0 |
| 0001213900-25-042751 | 6 | 4 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2025 | Accounts receivable | 1 |
| 0001213900-25-042751 | 6 | 5 | CF | 0 | H | Increase Decrease In Other Receivables | us-gaap/2025 | Other receivable | 1 |
| 0001213900-25-042751 | 6 | 6 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts payable | 0 |
| 0001213900-25-042751 | 6 | 7 | CF | 0 | H | Increase Decrease In Other Operating Liabilities | us-gaap/2025 | Other liabilities | 0 |
| 0001213900-25-042751 | 6 | 8 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Cash used in operating activities | 0 |
| 0001213900-25-042751 | 6 | 10 | CF | 0 | H | Proceeds From Related Party Debt | us-gaap/2025 | Advance from related party | 0 |
| 0001213900-25-042751 | 6 | 11 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Cash provided by financing activities | 0 |
| 0001213900-25-042751 | 6 | 12 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Effects of currency translation on cash | 0 |
| 0001213900-25-042751 | 6 | 13 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | Net decrease in cash | 0 |
| 0001213900-25-042751 | 6 | 14 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash at beginning of the period | 0 |
| 0001213900-25-042751 | 6 | 15 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash at end of period | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |